The results showed that PYGL expression was significantly higher in the WHO IV grade glioma tissues than that in WHO II grade group (P = 2.85e-56) and WHO III grade group (P = 1.16e-22; Figure 1A). The gene discussed is PYGL; the disease is glioma.